In a study that many breast cancer experts say may change practice, researchers have reported that extending the use of the drug tamoxifen to 10 years -- rather than the currently recommended five years -- could save lives by thwarting cancer's return.

Read more http://feeds.abcnews.com/click.phdo?i=a707add54c580801dc8aacf91b90cbe2